CLINICAL_TRIALS
trial_result
· 2023-10-10
Clinical Trial Update: Adrenomedullin for CADASIL [Phase 2]
Summary
Phase 2 clinical trial evaluating adrenomedullin for CADASIL has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Cerebral and Cardiovascular Center, Japan | Conditions: Cadasil | Phase 2 | Status: COMPLETED